世界の乳がんスクリーニング検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Breast Cancer Screening Tests Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0994 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、乳がんスクリーニング検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（身体検査、臨床検査、画像検査、遺伝子検査）、用途別市場規模（研究所、がん研究機関、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・乳がんスクリーニング検査の市場動向 ・企業の競争状況、市場シェア ・乳がんスクリーニング検査の種類別市場規模（身体検査、臨床検査、画像検査、遺伝子検査） ・乳がんスクリーニング検査の用途別市場規模（研究所、がん研究機関、診断センター、その他） ・乳がんスクリーニング検査の北米市場規模2016-2027（アメリカ、カナダ） ・乳がんスクリーニング検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・乳がんスクリーニング検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乳がんスクリーニング検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・乳がんスクリーニング検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Hologic、Siemens Healthcare、Carestream Health、Philips Healthcare、Shimadzu Corporation、Canon Medical Systems、Hitachi Medical Corporation、Esaote、Agilent Technologies） ・結論

Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the signs & symptoms of breast cancer. Breast cancer screening does not prevent the disease. However, detection in early stage increases the chances of recovery from the disease. Breast cancer screening tests are offered to women aged between 50-70 years as they are more prone to the disease.
Breast Cancer Screening Tests Market is primarily driven by a few key factors such as the patient awareness regarding rising healthcare concerns, increasing research for detection of various types of cancers, and prevention of disease. In addition to this, Breast Cancer Screening Tests Market also observes significant growth due to different government initiatives and public awareness campaigns.

Market Analysis and Insights: Global Breast Cancer Screening Tests Market
The global Breast Cancer Screening Tests market size is projected to reach US$ 1659.8 million by 2026, from US$ 1194 million in 2019, at a CAGR of 4.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Screening Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Screening Tests market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Screening Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Screening Tests market.

Global Breast Cancer Screening Tests Scope and Market Size
Breast Cancer Screening Tests market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Screening Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Physical Exam
Laboratory Tests
Imaging Tests
Genetic Tests

Segment by Application
Research Labs
Cancer Institutes
Diagnostic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Hologic
Siemens Healthcare
Carestream Health
Philips Healthcare
Shimadzu Corporation
Canon Medical Systems
Hitachi Medical Corporation
Esaote
Agilent Technologies

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Screening Tests Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Physical Exam
1.2.3 Laboratory Tests
1.2.4 Imaging Tests
1.2.5 Genetic Tests
1.3 Market by Application
1.3.1 Global Breast Cancer Screening Tests Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research Labs
1.3.3 Cancer Institutes
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Breast Cancer Screening Tests Market Perspective (2016-2027)
2.2 Breast Cancer Screening Tests Growth Trends by Regions
2.2.1 Breast Cancer Screening Tests Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breast Cancer Screening Tests Historic Market Share by Regions (2016-2021)
2.2.3 Breast Cancer Screening Tests Forecasted Market Size by Regions (2022-2027)
2.3 Breast Cancer Screening Tests Industry Dynamic
2.3.1 Breast Cancer Screening Tests Market Trends
2.3.2 Breast Cancer Screening Tests Market Drivers
2.3.3 Breast Cancer Screening Tests Market Challenges
2.3.4 Breast Cancer Screening Tests Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Screening Tests Players by Revenue
3.1.1 Global Top Breast Cancer Screening Tests Players by Revenue (2016-2021)
3.1.2 Global Breast Cancer Screening Tests Revenue Market Share by Players (2016-2021)
3.2 Global Breast Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Screening Tests Revenue
3.4 Global Breast Cancer Screening Tests Market Concentration Ratio
3.4.1 Global Breast Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Screening Tests Revenue in 2020
3.5 Breast Cancer Screening Tests Key Players Head office and Area Served
3.6 Key Players Breast Cancer Screening Tests Product Solution and Service
3.7 Date of Enter into Breast Cancer Screening Tests Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Screening Tests Breakdown Data by Type
4.1 Global Breast Cancer Screening Tests Historic Market Size by Type (2016-2021)
4.2 Global Breast Cancer Screening Tests Forecasted Market Size by Type (2022-2027)

5 Breast Cancer Screening Tests Breakdown Data by Application
5.1 Global Breast Cancer Screening Tests Historic Market Size by Application (2016-2021)
5.2 Global Breast Cancer Screening Tests Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Breast Cancer Screening Tests Market Size (2016-2027)
6.2 North America Breast Cancer Screening Tests Market Size by Type
6.2.1 North America Breast Cancer Screening Tests Market Size by Type (2016-2021)
6.2.2 North America Breast Cancer Screening Tests Market Size by Type (2022-2027)
6.2.3 North America Breast Cancer Screening Tests Market Size by Type (2016-2027)
6.3 North America Breast Cancer Screening Tests Market Size by Application
6.3.1 North America Breast Cancer Screening Tests Market Size by Application (2016-2021)
6.3.2 North America Breast Cancer Screening Tests Market Size by Application (2022-2027)
6.3.3 North America Breast Cancer Screening Tests Market Size by Application (2016-2027)
6.4 North America Breast Cancer Screening Tests Market Size by Country
6.4.1 North America Breast Cancer Screening Tests Market Size by Country (2016-2021)
6.4.2 North America Breast Cancer Screening Tests Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Breast Cancer Screening Tests Market Size (2016-2027)
7.2 Europe Breast Cancer Screening Tests Market Size by Type
7.2.1 Europe Breast Cancer Screening Tests Market Size by Type (2016-2021)
7.2.2 Europe Breast Cancer Screening Tests Market Size by Type (2022-2027)
7.2.3 Europe Breast Cancer Screening Tests Market Size by Type (2016-2027)
7.3 Europe Breast Cancer Screening Tests Market Size by Application
7.3.1 Europe Breast Cancer Screening Tests Market Size by Application (2016-2021)
7.3.2 Europe Breast Cancer Screening Tests Market Size by Application (2022-2027)
7.3.3 Europe Breast Cancer Screening Tests Market Size by Application (2016-2027)
7.4 Europe Breast Cancer Screening Tests Market Size by Country
7.4.1 Europe Breast Cancer Screening Tests Market Size by Country (2016-2021)
7.4.2 Europe Breast Cancer Screening Tests Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Screening Tests Market Size (2016-2027)
8.2 Asia-Pacific Breast Cancer Screening Tests Market Size by Type
8.2.1 Asia-Pacific Breast Cancer Screening Tests Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breast Cancer Screening Tests Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breast Cancer Screening Tests Market Size by Type (2016-2027)
8.3 Asia-Pacific Breast Cancer Screening Tests Market Size by Application
8.3.1 Asia-Pacific Breast Cancer Screening Tests Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breast Cancer Screening Tests Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breast Cancer Screening Tests Market Size by Application (2016-2027)
8.4 Asia-Pacific Breast Cancer Screening Tests Market Size by Region
8.4.1 Asia-Pacific Breast Cancer Screening Tests Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breast Cancer Screening Tests Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Breast Cancer Screening Tests Market Size (2016-2027)
9.2 Latin America Breast Cancer Screening Tests Market Size by Type
9.2.1 Latin America Breast Cancer Screening Tests Market Size by Type (2016-2021)
9.2.2 Latin America Breast Cancer Screening Tests Market Size by Type (2022-2027)
9.2.3 Latin America Breast Cancer Screening Tests Market Size by Type (2016-2027)
9.3 Latin America Breast Cancer Screening Tests Market Size by Application
9.3.1 Latin America Breast Cancer Screening Tests Market Size by Application (2016-2021)
9.3.2 Latin America Breast Cancer Screening Tests Market Size by Application (2022-2027)
9.3.3 Latin America Breast Cancer Screening Tests Market Size by Application (2016-2027)
9.4 Latin America Breast Cancer Screening Tests Market Size by Country
9.4.1 Latin America Breast Cancer Screening Tests Market Size by Country (2016-2021)
9.4.2 Latin America Breast Cancer Screening Tests Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Screening Tests Market Size (2016-2027)
10.2 Middle East & Africa Breast Cancer Screening Tests Market Size by Type
10.2.1 Middle East & Africa Breast Cancer Screening Tests Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breast Cancer Screening Tests Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breast Cancer Screening Tests Market Size by Type (2016-2027)
10.3 Middle East & Africa Breast Cancer Screening Tests Market Size by Application
10.3.1 Middle East & Africa Breast Cancer Screening Tests Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breast Cancer Screening Tests Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breast Cancer Screening Tests Market Size by Application (2016-2027)
10.4 Middle East & Africa Breast Cancer Screening Tests Market Size by Country
10.4.1 Middle East & Africa Breast Cancer Screening Tests Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breast Cancer Screening Tests Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Hologic
11.1.1 Hologic Company Details
11.1.2 Hologic Business Overview
11.1.3 Hologic Breast Cancer Screening Tests Introduction
11.1.4 Hologic Revenue in Breast Cancer Screening Tests Business (2016-2021)
11.1.5 Hologic Recent Development
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Details
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Breast Cancer Screening Tests Introduction
11.2.4 Siemens Healthcare Revenue in Breast Cancer Screening Tests Business (2016-2021)
11.2.5 Siemens Healthcare Recent Development
11.3 Carestream Health
11.3.1 Carestream Health Company Details
11.3.2 Carestream Health Business Overview
11.3.3 Carestream Health Breast Cancer Screening Tests Introduction
11.3.4 Carestream Health Revenue in Breast Cancer Screening Tests Business (2016-2021)
11.3.5 Carestream Health Recent Development
11.4 Philips Healthcare
11.4.1 Philips Healthcare Company Details
11.4.2 Philips Healthcare Business Overview
11.4.3 Philips Healthcare Breast Cancer Screening Tests Introduction
11.4.4 Philips Healthcare Revenue in Breast Cancer Screening Tests Business (2016-2021)
11.4.5 Philips Healthcare Recent Development
11.5 Shimadzu Corporation
11.5.1 Shimadzu Corporation Company Details
11.5.2 Shimadzu Corporation Business Overview
11.5.3 Shimadzu Corporation Breast Cancer Screening Tests Introduction
11.5.4 Shimadzu Corporation Revenue in Breast Cancer Screening Tests Business (2016-2021)
11.5.5 Shimadzu Corporation Recent Development
11.6 Canon Medical Systems
11.6.1 Canon Medical Systems Company Details
11.6.2 Canon Medical Systems Business Overview
11.6.3 Canon Medical Systems Breast Cancer Screening Tests Introduction
11.6.4 Canon Medical Systems Revenue in Breast Cancer Screening Tests Business (2016-2021)
11.6.5 Canon Medical Systems Recent Development
11.7 Hitachi Medical Corporation
11.7.1 Hitachi Medical Corporation Company Details
11.7.2 Hitachi Medical Corporation Business Overview
11.7.3 Hitachi Medical Corporation Breast Cancer Screening Tests Introduction
11.7.4 Hitachi Medical Corporation Revenue in Breast Cancer Screening Tests Business (2016-2021)
11.7.5 Hitachi Medical Corporation Recent Development
11.8 Esaote
11.8.1 Esaote Company Details
11.8.2 Esaote Business Overview
11.8.3 Esaote Breast Cancer Screening Tests Introduction
11.8.4 Esaote Revenue in Breast Cancer Screening Tests Business (2016-2021)
11.8.5 Esaote Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Breast Cancer Screening Tests Introduction
11.9.4 Agilent Technologies Revenue in Breast Cancer Screening Tests Business (2016-2021)
11.9.5 Agilent Technologies Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Breast Cancer Screening Tests Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Physical Exam
Table 3. Key Players of Laboratory Tests
Table 4. Key Players of Imaging Tests
Table 5. Key Players of Genetic Tests
Table 6. Global Breast Cancer Screening Tests Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Breast Cancer Screening Tests Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Breast Cancer Screening Tests Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Breast Cancer Screening Tests Market Share by Regions (2016-2021)
Table 10. Global Breast Cancer Screening Tests Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Breast Cancer Screening Tests Market Share by Regions (2022-2027)
Table 12. Breast Cancer Screening Tests Market Trends
Table 13. Breast Cancer Screening Tests Market Drivers
Table 14. Breast Cancer Screening Tests Market Challenges
Table 15. Breast Cancer Screening Tests Market Restraints
Table 16. Global Breast Cancer Screening Tests Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Breast Cancer Screening Tests Market Share by Players (2016-2021)
Table 18. Global Top Breast Cancer Screening Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Screening Tests as of 2020)
Table 19. Ranking of Global Top Breast Cancer Screening Tests Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Breast Cancer Screening Tests Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Breast Cancer Screening Tests Product Solution and Service
Table 23. Date of Enter into Breast Cancer Screening Tests Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Breast Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Breast Cancer Screening Tests Revenue Market Share by Type (2016-2021)
Table 27. Global Breast Cancer Screening Tests Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Breast Cancer Screening Tests Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Breast Cancer Screening Tests Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Breast Cancer Screening Tests Revenue Market Share by Application (2016-2021)
Table 31. Global Breast Cancer Screening Tests Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Breast Cancer Screening Tests Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Breast Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Breast Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Breast Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Breast Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Breast Cancer Screening Tests Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Breast Cancer Screening Tests Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Breast Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Breast Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Breast Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Breast Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Breast Cancer Screening Tests Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Breast Cancer Screening Tests Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Breast Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Breast Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Breast Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Breast Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Breast Cancer Screening Tests Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Breast Cancer Screening Tests Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Breast Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Breast Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Breast Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Breast Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Breast Cancer Screening Tests Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Breast Cancer Screening Tests Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Breast Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Breast Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Breast Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Breast Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Breast Cancer Screening Tests Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Breast Cancer Screening Tests Market Size by Country (2022-2027) & (US$ Million)
Table 63. Hologic Company Details
Table 64. Hologic Business Overview
Table 65. Hologic Breast Cancer Screening Tests Product
Table 66. Hologic Revenue in Breast Cancer Screening Tests Business (2016-2021) & (US$ Million)
Table 67. Hologic Recent Development
Table 68. Siemens Healthcare Company Details
Table 69. Siemens Healthcare Business Overview
Table 70. Siemens Healthcare Breast Cancer Screening Tests Product
Table 71. Siemens Healthcare Revenue in Breast Cancer Screening Tests Business (2016-2021) & (US$ Million)
Table 72. Siemens Healthcare Recent Development
Table 73. Carestream Health Company Details
Table 74. Carestream Health Business Overview
Table 75. Carestream Health Breast Cancer Screening Tests Product
Table 76. Carestream Health Revenue in Breast Cancer Screening Tests Business (2016-2021) & (US$ Million)
Table 77. Carestream Health Recent Development
Table 78. Philips Healthcare Company Details
Table 79. Philips Healthcare Business Overview
Table 80. Philips Healthcare Breast Cancer Screening Tests Product
Table 81. Philips Healthcare Revenue in Breast Cancer Screening Tests Business (2016-2021) & (US$ Million)
Table 82. Philips Healthcare Recent Development
Table 83. Shimadzu Corporation Company Details
Table 84. Shimadzu Corporation Business Overview
Table 85. Shimadzu Corporation Breast Cancer Screening Tests Product
Table 86. Shimadzu Corporation Revenue in Breast Cancer Screening Tests Business (2016-2021) & (US$ Million)
Table 87. Shimadzu Corporation Recent Development
Table 88. Canon Medical Systems Company Details
Table 89. Canon Medical Systems Business Overview
Table 90. Canon Medical Systems Breast Cancer Screening Tests Product
Table 91. Canon Medical Systems Revenue in Breast Cancer Screening Tests Business (2016-2021) & (US$ Million)
Table 92. Canon Medical Systems Recent Development
Table 93. Hitachi Medical Corporation Company Details
Table 94. Hitachi Medical Corporation Business Overview
Table 95. Hitachi Medical Corporation Breast Cancer Screening Tests Product
Table 96. Hitachi Medical Corporation Revenue in Breast Cancer Screening Tests Business (2016-2021) & (US$ Million)
Table 97. Hitachi Medical Corporation Recent Development
Table 98. Esaote Company Details
Table 99. Esaote Business Overview
Table 100. Esaote Revenue in Breast Cancer Screening Tests Business (2016-2021) & (US$ Million)
Table 101. Esaote Recent Development
Table 102. Agilent Technologies Company Details
Table 103. Agilent Technologies Business Overview
Table 104. Agilent Technologies Breast Cancer Screening Tests Product
Table 105. Agilent Technologies Revenue in Breast Cancer Screening Tests Business (2016-2021) & (US$ Million)
Table 106. Agilent Technologies Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Screening Tests Market Share by Type: 2020 VS 2027
Figure 2. Physical Exam Features
Figure 3. Laboratory Tests Features
Figure 4. Imaging Tests Features
Figure 5. Genetic Tests Features
Figure 6. Global Breast Cancer Screening Tests Market Share by Application: 2020 VS 2027
Figure 7. Research Labs Case Studies
Figure 8. Cancer Institutes Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Breast Cancer Screening Tests Report Years Considered
Figure 12. Global Breast Cancer Screening Tests Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Breast Cancer Screening Tests Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Breast Cancer Screening Tests Market Share by Regions: 2020 VS 2027
Figure 15. Global Breast Cancer Screening Tests Market Share by Regions (2022-2027)
Figure 16. Global Breast Cancer Screening Tests Market Share by Players in 2020
Figure 17. Global Top Breast Cancer Screening Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Screening Tests as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Breast Cancer Screening Tests Revenue in 2020
Figure 19. Global Breast Cancer Screening Tests Revenue Market Share by Type (2016-2021)
Figure 20. Global Breast Cancer Screening Tests Revenue Market Share by Type (2022-2027)
Figure 21. North America Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Breast Cancer Screening Tests Market Share by Type (2016-2027)
Figure 23. North America Breast Cancer Screening Tests Market Share by Application (2016-2027)
Figure 24. North America Breast Cancer Screening Tests Market Share by Country (2016-2027)
Figure 25. United States Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Breast Cancer Screening Tests Market Share by Type (2016-2027)
Figure 29. Europe Breast Cancer Screening Tests Market Share by Application (2016-2027)
Figure 30. Europe Breast Cancer Screening Tests Market Share by Country (2016-2027)
Figure 31. Germany Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Breast Cancer Screening Tests Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Breast Cancer Screening Tests Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Breast Cancer Screening Tests Market Share by Region (2016-2027)
Figure 41. China Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Breast Cancer Screening Tests Market Share by Type (2016-2027)
Figure 49. Latin America Breast Cancer Screening Tests Market Share by Application (2016-2027)
Figure 50. Latin America Breast Cancer Screening Tests Market Share by Country (2016-2027)
Figure 51. Mexico Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Breast Cancer Screening Tests Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Breast Cancer Screening Tests Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Breast Cancer Screening Tests Market Share by Country (2016-2027)
Figure 57. Turkey Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Breast Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Hologic Revenue Growth Rate in Breast Cancer Screening Tests Business (2016-2021)
Figure 61. Siemens Healthcare Revenue Growth Rate in Breast Cancer Screening Tests Business (2016-2021)
Figure 62. Carestream Health Revenue Growth Rate in Breast Cancer Screening Tests Business (2016-2021)
Figure 63. Philips Healthcare Revenue Growth Rate in Breast Cancer Screening Tests Business (2016-2021)
Figure 64. Shimadzu Corporation Revenue Growth Rate in Breast Cancer Screening Tests Business (2016-2021)
Figure 65. Canon Medical Systems Revenue Growth Rate in Breast Cancer Screening Tests Business (2016-2021)
Figure 66. Hitachi Medical Corporation Revenue Growth Rate in Breast Cancer Screening Tests Business (2016-2021)
Figure 67. Esaote Revenue Growth Rate in Breast Cancer Screening Tests Business (2016-2021)
Figure 68. Agilent Technologies Revenue Growth Rate in Breast Cancer Screening Tests Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---